Navigation Links
Intarcia Presents Compelling 48-week Results for ITCA 650 - Data Underlines the Promise to Become the First Injection-free GLP-1 Therapy at the 47th Annual EASD Meeting in Lisbon
Date:9/14/2011

se arms.

ITCA 650 dose weeks 13-48

20 mcg/day

40 mcg/day

60 mcg/day

80 mcg/dayMean baseline HbA1c (%)

7.8

7.8

8.1

7.9Mean week 48 HbA1c (%)

6.8

6.8

6.6

6.5Mean HbA1c change at week 48 (%)

-1.0

-1.0

-1.5

-1.4Mean weight change at week 48 (lbs)

-6.0

-10.8

-7.7

-7.9Based on the robust treatment response observed at the week-24 study endpoint and the durability of response observed at week 48, a starting dose of ITCA 650 20 mcg/day for weeks 1-12 followed by transition to ITCA 650 60 mcg/day appears to provide the greatest incremental reductions in HbA1c, FPG and body weight with the most favorable tolerability profile.

Throughout the extended treatment duration of the study, there were no treatment discontinuations due to nausea.  Numeric improvements were observed in measures of blood pressure and lipids at weeks 24 and 48 compared to baseline.

"Testing novel therapies over longer treatment durations is very important to confirm sustained effects, safety and tolerability," said Julio Rosenstock, MD, ITCA 650 phase 2 study principal investigator.  "These encouraging findings warrant further investigation of the optimized dose regimen of ITCA 650 20 to 60 mcg/day in larger phase 3 studies and using longer duration devices."  

Patient Satisfaction with ITCA 650 TherapyIn a separate session focusing on new GLP-1 therapies, Thomas R. Alessi, PhD, Intarcia's Vice President, Development, presented the results of a treatment satisfaction survey that was administered to patients before the beginning of the ITCA 650 phase 2 clinical study and at study weeks 8 and 20.  The survey utilized the Diabetes Medication Satisfaction Tool (DM-SAT), a validated and published self-assessment tool.  Study results indicated that patients receiving ITCA 650 at doses of either 20 mcg/day or 40
'/>"/>

SOURCE Intarcia Therapeutics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
2. Intarcia Therapeutics Names Kurt Graves Executive Chairman to Advance Strategic Interests and Broaden Commercial Goals
3. Intarcia Presents Positive ITCA 650 Phase 2 Study Results for Type 2 Diabetes at EASD
4. Intarcia Therapeutics Executive Chairman Kurt Graves to Present at 29th Annual JP Morgan Healthcare Conference
5. Intarcia Announces Presentations of Three Clinical Abstracts at the 47th Annual Meeting of the European Association for the Study of Diabetes
6. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
7. EntreMed Presents Data for Phase 2 Study of MKC-1 in Metastatic Breast Cancer
8. Pharmasset Presents R7128 Phase 1 Single Ascending Dose Study in Healthy Volunteers
9. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
10. CEL-SCI Presents Data for CEL-1000 as a Vaccine Adjuvant with Recombinant Hepatitis B Virus Protein
11. Ardea Biosciences, Inc. Presents Results of Phase 1 Studies of RDEA806, a Novel NNRTI for HIV, at 47th ICAAC
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015  The Mesothelioma Victims ... victims of mesothelioma get the best possible compensation, ... individuals with this rare cancer caused by exposure ... up-to-date information related to treatment options such as ... call the Mesothelioma Victims Center anytime at 866-714-6466. ...
(Date:5/22/2015)... 20, 2015 Research and Markets( http://www.researchandmarkets.com/research/28m7nx/guide_to_prepare ... "Guide to Prepare Application Dossiers for Oversea Medical ... " report to their offering. ... segment market of the most growth potentiality, which ... manufacturers and producers to penetrate such market. It ...
(Date:5/22/2015)... , May 22, 2015 Research and Markets ... addition of the "Latest Regulations on Pharmaceutical ... to their offering. This is first ... a guidance on international multi-center clinical trials of ... has begun to be implemented on March 1, ...
Breaking Medicine Technology:Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 2China Guide to Prepare Application Dossiers for Oversea Medical Device Registration and Recordation 32015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... DIEGO, April 14, 2011 LifeVantage Corporation (OTCBB: ... preliminary net revenue for its third fiscal quarter of 2011 ... $2.6 million or 35% over net revenue of $7.4 million ... is also an approximate $7.3 million or 270% increase in ...
... Attorney General Roy Cooper warned the House Special Select ... immunity to pharmaceutical companies could cost North Carolina taxpayers ... dollars." Still, the GOP-controlled committee, led by ... could go to the House floor for a vote ...
Cached Medicine Technology:LifeVantage Announces Preliminary Third Quarter 2011 Revenue 2GOP's Big Pharma Protection to Cost NC Taxpayers "Hundreds of Millions" 2
(Date:5/24/2015)... 24, 2015 ... - The students were selected ... the fourth annual A Day of ... Geneva National in Lake Geneva. , ... High School,         Jonathan Alfonso,         Bridget Keefe, ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 With the ... businesses, are finding it increasingly difficult to provide their ... fail to provide adequate insurance for employees stand to ... been such an integral part of a business’s success ... healthcare for businesses, Online USA Doctors has created a ...
(Date:5/23/2015)... Javon Bea Mercy Health System CEO ... Center, 557 N. Washington St., Janesville, will host an ... pm. , The 8-week clinic is lead by Brent ... who will offer training that encompasses a warm-up, training ... show selection and weekly training plans. , The program ...
(Date:5/22/2015)... The American College of Traditional Chinese ... They will hold a webinar on the updates of ... on Classical Chinese Medicine. , Webinar – First Professional ... the Dean of Clinical Education, will lead this webinar ... Doctorate program. ACTCM is currently developing this degree program ...
(Date:5/22/2015)... May 22, 2015 Omar Ahmad Barrada, ... to participate in the 2015 Congress of Future Medical ... as a gathering of “America’s highest achieving high school ... of healthcare, set new goals and learn better study ... live surgery, during which we can ask the surgeons ...
Breaking Medicine News(10 mins):Health News:Mercy Foundation Honors 16 Students for Making a Difference - Mercy Health System Javon Bea 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 2Health News:Online USA Doctors Now Offers Cost-Saving Alternative Healthcare for Businesses 3Health News:ACTCM Announces Upcoming June Events 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2
... Amanda Gardner HealthDay Reporter , TUESDAY, Nov. 16 ... defective one, scientists were able to partially restore the heart,s ... "This is the first time gene therapy has been ... heart failure," study lead author Dr. Donna Mancini, professor of ...
... prescription filled can undermine medical treatment, result in increased ... the patient. An editorial in the Nov. 16 issue ... the problem and issues a call to action. ... Nonadherence," Michael D. Murray, PharmD, MPH, a Regenstrief Institute, ...
... HealthDay Reporter , MONDAY, Nov. 15 (HealthDay News) ... those involved: Sometimes surgical instruments and sponges are left inside ... Children suffering from such mishaps were not more likely ... are more than twice as long and cost more than ...
... 1 and 1-1/2, children who get most of their sleep at ... variety of skill areas than children who don,t sleep as much ... conducted by researchers at the University of Montreal and the University ... the journal Child Development . The study, of 60 ...
... cancer appear more likely to experience hearing loss and to ... not receive such treatment, according to a report in the ... , one of the JAMA/Archives journals. Head and neck ... according to background information in the article. Treatment methods include ...
... MONDAY, Nov. 15 (HealthDay News) -- In Australia, where universal ... much more prevalent among poor citizens than it is among ... researchers say that differences in risk do exist between the ... heart disease is typically thought of as more prevalent in ...
Cached Medicine News:Health News:Gene Therapy Shows Potential Against Heart Failure 2Health News:Not following doctor's orders: Prescription abandonment 2Health News:Sponges, Surgical Tools Sometimes Left in Kids After Operation 2Health News:Sponges, Surgical Tools Sometimes Left in Kids After Operation 3Health News:Nighttime sleep found beneficial to infants' skills 2Health News:Hearing loss common following radiation therapy for head and neck cancer 2Health News:Universal Health Care May Lessen Income's Impact on Heart Disease 2
... Catheter is indicated for balloon ... of a coronary artery or ... purpose of improving myocardial perfusion. ... also designed to provide distal ...
16mm from Mid-screw to Tips, blunt tips; overall length 110mm; Stainless Steel...
Angled 45 Degrees to Right, 9.5mm blade, gently curved .5x .25mm blunt tips; Lower blade is 0.5mm longer; 14mm from mid screw to tip; (Available in left and right; ) overall length 120mm; Stainless ...
Two prong stainless steel tips; with titanium handle/...
Medicine Products: